EnFocus 2300, EnFocus 4400— 510(k) K162783

Substantially Equivalent

Bioptigen, Inc.

FDA 510(k) clearance K162783 for EnFocus 2300, EnFocus 4400, Substantially Equivalent on 2016-12-09. Applicant: Bioptigen, Inc.. Device class: 2.

Clearance details

Applicant: Bioptigen, Inc.
Product code: Code OBO
Device class: Class 2
Regulation: 21 CFR 886.1570
Advisory panel: Ophthalmic
Date received: 2016-10-03
Decision date: 2016-12-09
Decision: Substantially Equivalent
Clearance type: Special
Location: Morrisville, NC, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code OBO

K261019 — ANTERION2026-09-11
K253837 — SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex Module2026-05-07
K252633 — UNITY DX (UDX)2025-12-23
K250553 — Tomey Cornea/Anterior Segment OCT (CASIA2)2025-07-18
K250868 — SPECTRALIS HRA+OCT and variants2025-05-12

More clearances from Bioptigen, Inc.

K150722 — EnFocus 2300, EnFocus 44002015-12-02
K120057 — ENVISU SPECTRAL DOMAIN OPHTHALMIC IMAGING SYSTEM (SDOIS)2012-05-11
K063343 — BIOPTIGEN SPECTRAL DOMAIN OPHTHALMIC IMAGING SYSTEM2006-12-13

Data sourced from openFDA. This site is unofficial and independent of the FDA.